Total Lymphocyte Count (TLC) Is a Useful Tool for the Timing of Opportunistic Infection Prophylaxis in India and Other Resource-Constrained Countries
Authors:
- N. KumarasamyNKN. Kumarasamy
- Anish P. MahajanAMAnish P. Mahajan
- Timothy P. FlaniganTFTimothy P. Flanigan
- R. HemalathaRHR. Hemalatha
- Kenneth H. MayerKMKenneth H. Mayer
- Charles C. J. CarpenterCCCharles C. J. Carpenter
- S. P. ThyagarajanSTS. P. Thyagarajan
- Suniti SolomonSSSuniti Solomon
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 31 (4) , 378-383
Abstract
In most resource-constrained countries, CD4 cell count testing is prohibitively expensive for routine clinical use and is not widely available. As a result, physicians are often required to make decisions about opportunistic infection (OI) chemoprophylaxis without a laboratory evaluation of HIV stage and level of immunosuppression. To evaluate the correlation of total lymphocyte count (TLC), an inexpensive and widely available parameter, to CD4 count. To determine a range of TLC cutoffs for the initiation of OI prophylaxis that is appropriate for resource-constrained settings. Spearman correlation between CD4 count and TLC was assessed in patients attending an HIV/AIDS clinic in South India. Positive predictive value (PPV), negative predictive value (NPV), and sensitivity and specificity of various TLC cutoffs were computed for CD4 count <200 cells/mm3 and <350 cells/mm3. Correlation and statistical indices computed for all patients and for patients dually infected with HIV and active tuberculosis. High degree of correlation was noted between 650 paired CD4 and TLC counts (r = 0.744). TLC <1400 cells/mm3 had a 76% PPV, 86% NPV, and was 73% sensitive, 88% specific for CD4 count <200 cells/mm3. TLC <1700 cells/mm3 had a 86% PPV, 69% NPV, and was 70% sensitive, 86% specific for CD4 count <350 cells/mm3. The cost of a single CD4 count in India is approximately US $30, whereas the cost of a single TLC is US $0.80. TLC could serve as a low-cost tool for determining both a patient’s risk of OI and when to initiate prophylaxis in resource-constrained settings. PPV, NPV, sensitivity, and specificity maximally aggregated at TLC <1400 cells/mm3 for CD4 <200 cell/mm3 and TLC <1700 cells/mm3 for CD4 <350 cells/mm3. Selection of appropriate TLC cutoffs for prophylaxis administration should be made on a regional basis depending on OI incidence, antimicrobial resistance patterns, and availability of the antimicrobials.Keywords
This publication has 23 references indexed in Scilit:
- Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendationsAIDS, 2001
- GLOBAL DIMENSIONS OF THE AIDS EPIDEMIC:Infectious Disease Clinics of North America, 2000
- Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trialThe Lancet, 1999
- Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 InfectionAnnals of Internal Medicine, 1997
- Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfectInternational Journal of STD & AIDS, 1996
- Delayed-Type Hypersensitivity Testing in Tanzanian Adults with HIV InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons1993
- The Relationship of Total Lymphocyte Count to CD4 Lymphocyte Counts in Patients Infected with Human Immunodeficiency VirusThe American Journal of the Medical Sciences, 1992
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990